Crossmark

Impact of systemic inflammatory markers in patients with <i>ALK</i> -positive non-small cell lung cancer treated with crizotinib

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2022.11.006

Published Online: 2025-03-10

Published Print: 2023-11-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Olmez, O.F.

Bilici, A.

Gursoy, P.

Cubukcu, E.

Sakin, A.

Korkmaz, T.

Cil, I. https://orcid.org/0000-0002-6388-0346
Cakar, B.

Menekse, S.

Demir, T.

Acikgoz, O.

Hamdard, J. https://orcid.org/0000-0002-5823-1704
License Information

Version of Record valid from 2023-11-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2022-06-19

Accepted: 2022-11-24

Published: 2025-03-10